首页> 美国卫生研究院文献>other >The Value of SPECT/CT in Monitoring Prefabricated Tissue-Engineered Bone and Orthotopic rhBMP-2 Implants for Mandibular Reconstruction
【2h】

The Value of SPECT/CT in Monitoring Prefabricated Tissue-Engineered Bone and Orthotopic rhBMP-2 Implants for Mandibular Reconstruction

机译:SPECT / CT在监测预制组织工程骨和原位rhBMP-2种植体对下颌骨重建中的价值

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Bone tissue engineering shows good prospects for mandibular reconstruction. In recent studies, prefabricated tissue-engineered bone (PTEB) by recombinant human bone morphogenetic proteins (rhBMPs) applied in vivo has found to be an effective alternative for autologous bone grafts. However, the optimal time to transfer PTEB for mandibular reconstruction is still not elucidated. Thus, here in an animal experiment of rhesus monkey, the suitable transferring time for PTEB to reconstruct mandibular defects was evaluated by 99mTc-MDP SPECT/CT, and its value in monitoring orthotopic rhBMP-2 implants for mandibular reconstruction was also evaluated. The result of SPECT/CT showed higher 99mTc-MDP uptake, indicating osteoinductivity, in rhBMP-2 incorporated demineralized freeze-dried bone allograft (DFDBA) and coralline hydroxyapatite (CHA) implants than those without BMP stimulation. 99mTc-MDP uptake of rhBMP-2 implant peaked at 8 weeks following implantation while CT showed the density of these implants increased after 13 weeks’ prefabrication. Histology confirmed that mandibular defects were repaired successfully with PTEB or orthotopically rhBMP-2 incorporated CHA implants, in accordance with SPECT/CT findings. Collectively, data shows 99mTc-MDP SPECT/CT is a sensitive and noninvasive tool to monitor osteoinductivity and bone regeneration of PTEB and orthotopic implants. The PTEB achieved peak osteoinductivity and bone density at 8 to 13 weeks following ectopic implantation, which would serve as a recommendable time frame for its transfer to mandibular reconstruction.
机译:骨组织工程显示下颌重建的良好前景。在最近的研究中,通过体内应用重组人骨形态发生蛋白(rhBMP)预制的组织工程化骨(PTEB)已被发现是自体骨移植物的有效替代品。但是,仍未阐明转移PTEB用于下颌骨重建的最佳时间。因此,在恒河猴的动物实验中,用 99m Tc-MDP SPECT / CT评估了PTEB重建下颌骨缺损的合适转移时间,及其在监测原位rhBMP-2植入物中的价值。还评估了下颌重建。 SPECT / CT结果显示,掺入脱矿质冻干同种异体骨移植(DFDBA)和珊瑚碱羟基磷灰石(CHA)的rhBMP-2植入物的 99m Tc-MDP摄取量较高,这表明其骨诱导性高于没有BMP刺激的植入物。在植入后8周, 99m Tc-MDP对rhBMP-2植入物的吸收达到峰值,而CT显示,预制13周后,这些植入物的密度增加。组织学证实,根据SPECT / CT研究结果,PTEB或原位整合rhBMP-2的CHA植入物可成功修复下颌骨缺损。总体而言,数据显示 99m Tc-MDP SPECT / CT是一种灵敏且无创的工具,可监测PTEB和原位植入物的骨诱导性和骨再生。异位植入后PTEB在异位植入后8到13周达到了峰值骨诱导性和骨密度,这可作为将其转移至下颌骨重建的推荐时间范围。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号